Skip to main content

Table 1 Infection burden of VVC in groups receiving different treatments pior-infection

From: Enhanced antifungal activity of bovine lactoferrin-producing probiotic Lactobacillus casei in the murine model of vulvovaginal candidiasis

Treatment

Infection burden of VVC (log10 CFU) post-inoculation

PBS

4.585 ± 0.112

L.casei/pPG612.1-BLF

4.404 ± 0.040*

L.casei/pPG612.1

4.643 ± 0.035

L.casei

4.633 ± 0.032

  1. *P < 0.01 in comparison with PBS, L.casei/pPG612.1-BLF and L.casei groups